| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/14/2013 | CN102652757B Application of health-care drinking liquid containing deep seawater in preparation of medicaments or health-care products for preventing or treating metabolic syndrome |
| 08/14/2013 | CN102614462B Traditional Chinese medicine composition for curing coronary disease and preparation method thereof |
| 08/14/2013 | CN102614234B Anti-stroke medicinal composition, tablet and preparation methods thereof |
| 08/14/2013 | CN102614160B Use of shikimic acid in preparation of antihypertensive drug |
| 08/14/2013 | CN102614135B Cytidine disodium triphosphate suspension powder injection and preparation method thereof |
| 08/14/2013 | CN102552196B Spray-drying method for preparing metoprolol succinate sustained-release capsules |
| 08/14/2013 | CN102526631B Traditional Chinese medicine preparation, tablet and capsule for curing dilated cardiomyopathy and preparation method |
| 08/14/2013 | CN102526608B Preparation method of traditional Chinese medicine for treating heart blood stasis type palpitation |
| 08/14/2013 | CN102526173B Chinese medicinal formulation for treating coronary heart disease and cerebral thrombosis |
| 08/14/2013 | CN102475884B Application of four polypeptides in preparation ACE inhibitor and antihypertensive drug |
| 08/14/2013 | CN102406924B Medicine composition for treating cerebrovascular and cardiovascular diseases as well as preparation method and application thereof |
| 08/14/2013 | CN102406769B Traditional Chinese medicinal preparation for treating hypertension, hyperlipidemia, arteriosclerosis and coronary heart disease, and preparation method thereof |
| 08/14/2013 | CN102370724B Hemiplegia treatment ointment for treating cerebrovascular diseases |
| 08/14/2013 | CN102370723B Self-heated traditional Chinese medicine (TCM) emplastrum for improving chest bi |
| 08/14/2013 | CN102327272B Oral solid pharmaceutical composition and preparation method thereof |
| 08/14/2013 | CN102327264B Pharmaceutical composition of amlodipine and telmisartan and preparation method of pharmaceutical composition |
| 08/14/2013 | CN102302681B Medicinal composition for treating cerebral infarction |
| 08/14/2013 | CN102205016B Medicament for treating phlegm and blood stasis coronary heart disease caused by atherosclerosis |
| 08/14/2013 | CN102114004B Double-layer sustained-release nifedipine tablet and preparation method thereof |
| 08/14/2013 | CN101897754B Preparation method of polyethylene glycol 12-hydroxy stearate-containing danshen root medicament injection preparation |
| 08/14/2013 | CN101838260B Dihydropyrrolones derivative as Caspase-3 inhibitor |
| 08/14/2013 | CN101830916B Cefbuperazone sodium hydrate, preparation method thereof and application thereof |
| 08/14/2013 | CN101664551B Stabilization of hypoxia inducible factor (HIF) alpha |
| 08/14/2013 | CN101490038B Pyrimidine derivatives as ALK-5 inhibitors |
| 08/14/2013 | CN101486682B N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 08/14/2013 | CN101467985B Bisoprolol fumarate dispersible tablet and preparation method thereof |
| 08/14/2013 | CN101282946B 半胱氨酸蛋白酶抑制剂及它们的治疗应用 Cysteine protease inhibitors and their therapeutic applications |
| 08/14/2013 | CN101106986B Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 08/13/2013 | US8507473 3H-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of GPR81 receptor disorders |
| 08/13/2013 | US8507433 Cardioprotective effects of GHRH agonists |
| 08/13/2013 | US8507010 Compositions comprising quinazoline derivatives |
| 08/13/2013 | CA2768841C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2768828C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2768773C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2743539C Angiotensin-converting enzyme inhibitory peptides |
| 08/13/2013 | CA2743313C Angiotensin-converting enzyme inhibitory peptides |
| 08/13/2013 | CA2706354C Use of hydrogen fumarate and dihydrogen phosphate salts of meldonium in treating or preventing atherosclerosis |
| 08/13/2013 | CA2580409C Triazole derivative or salt thereof |
| 08/13/2013 | CA2571462C Composition for preventing recurrence of stroke |
| 08/13/2013 | CA2569888C Use of l-carnitine for the treatment of cardiovascular diseases |
| 08/13/2013 | CA2543406C Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption |
| 08/13/2013 | CA2526891C Angiotensin-converting enzyme inhibitory peptides |
| 08/13/2013 | CA2464121C Pregnancy-associated plasma protein-a2 (papp-a2) |
| 08/13/2013 | CA2455832C Method for dip coating medical devices with an aqueous latex polymeric emulsion |
| 08/13/2013 | CA2410224C Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 08/08/2013 | WO2013116194A2 Method of treating or limiting development of heart failure with preserved ejection fraction and tissue fibrosis |
| 08/08/2013 | WO2013113860A1 Fused pyrroledicarboxamides and their use as pharmaceuticals |
| 08/08/2013 | WO2013113799A1 Phenyl -c-oxadiazole derivatives as inhibitors of leukotriene production combination therapy |
| 08/08/2013 | WO2013113060A1 Peptide |
| 08/08/2013 | US20130203977 Oligonucleotides comprising alternating segments and uses thereof |
| 08/08/2013 | US20130203870 Animal Models of Atherosclerosis |
| 08/08/2013 | US20130203805 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase |
| 08/08/2013 | US20130203790 Sulfur-containing compounds as anti-proliferative agents |
| 08/08/2013 | US20130203767 Treatment of Pulmonary Hypertension |
| 08/07/2013 | EP2623512A1 Peptide capable of binding to immunoglobulin |
| 08/07/2013 | EP2623504A1 5,6-Disubstituted oxindole derivatives and their use in the manufacture of a medicament for the treatment of vasopressin-dependent diseases |
| 08/07/2013 | EP2623499A1 1,2,4-triazolone derivative |
| 08/07/2013 | EP2623491A2 Piperidine and piperazine derivatives as autotaxin inhibitors |
| 08/07/2013 | EP2621534A2 Selective removal of age-modified cells for treatment of ather0sclerosis |
| 08/07/2013 | EP2621278A1 Alpha-ketoamide derivatives useful endothelial lipase inhibitors |
| 08/07/2013 | EP2621273A2 Polyphosphate and pyrophosphate derivative of saccharides |
| 08/07/2013 | CN203107746U Aspirin dipyridamole slow-release structure |
| 08/07/2013 | CN203107745U Aspirin dipyridamole slow-release structure |
| 08/07/2013 | CN103237806A Peptide capable of binding to immunoglobulin |
| 08/07/2013 | CN103237797A Quinolin-4 (1h)-ketone derivatives as inhibitors of phosphatidylinositol 3-kinases |
| 08/07/2013 | CN103237548A Use of A2B adenosine receptor antagonists for treating pulmonary hypertension |
| 08/07/2013 | CN103237542A Liposomal formulation of dalcetrapib |
| 08/07/2013 | CN103232543A Recombinant protein Tumstatin-CD137L4 with Tumstatin activities as well as preparation method and application thereof |
| 08/07/2013 | CN103232540A Domain antibody construct |
| 08/07/2013 | CN103232537A Preparation method and use of mustelus griseus cartilage blood vessel generation inhibiting factor |
| 08/07/2013 | CN103232446A Oxazolidinone derivative crystal form II and preparation method and application thereof |
| 08/07/2013 | CN103232395A Sodium ozagrel compound, preparation method and drug composition thereof |
| 08/07/2013 | CN103232350A Acylated Danshensu derivative and application thereof to preventing and treating cerebrovascular and liver and kidney diseases |
| 08/07/2013 | CN103230594A Medicine composition of alpha-glucosidase inhibitor and vitamin B |
| 08/07/2013 | CN103230592A Composition of statin medicine and 5-methyltetrahydrofolic acid, and application thereof |
| 08/07/2013 | CN103230590A Interleukin-1 conjugates and uses thereof |
| 08/07/2013 | CN103230587A Composition of crocodile hemoglobin peptide and preparation method of composition |
| 08/07/2013 | CN103230560A Traditional Chinese medicine formula for treating cerebral ischemic stroke |
| 08/07/2013 | CN103230548A Traditional Chinese medicine composition for treating pulmonary heart disease |
| 08/07/2013 | CN103230538A Fresh dendrobium officinale American ginseng particle and preparation method thereof |
| 08/07/2013 | CN103230491A Orally taken and external combined miao medicine for treating haemorrhoids and preparation method thereof |
| 08/07/2013 | CN103230482A Extract for reducing blood pressure and adjusting blood fat and its preparation method and use |
| 08/07/2013 | CN103230478A Selenium-rich natto product |
| 08/07/2013 | CN103230474A Rose-pine needle distillate oral liquid and preparation method thereof |
| 08/07/2013 | CN103230469A Hemorrhoid rehabilitation traditional Chinese medicine |
| 08/07/2013 | CN103230459A Sole acupoint plaster |
| 08/07/2013 | CN103230457A Traditional Chinese medicine composition for treating viral myocarditis and preparation method and use thereof |
| 08/07/2013 | CN103230451A Drug for preventing and treating cardia-cerebrovascular diseases and hepatopathy and preparation method thereof |
| 08/07/2013 | CN103230448A Coptis and colla corii asini decoction compound formula granule, as well as preparation method and detection method thereof |
| 08/07/2013 | CN103230445A External application hemorrhoid treatment traditional Chinese medicine and preparation method thereof |
| 08/07/2013 | CN103230443A Traditional Chinese medical composition for treating hypertension |
| 08/07/2013 | CN103230442A Xanthium sibiricum Patr.ex Widd external medical composition for treating swelling and preparation method thereof |
| 08/07/2013 | CN103230438A Traditional Chinese medicine for treating inflammatory external hemorrhoid |
| 08/07/2013 | CN103230426A Medical composition for treating diabetes mellitus and complications thereof |
| 08/07/2013 | CN103230414A Materials and methods for treating and managing angiogenesis-mediated diseases |
| 08/07/2013 | CN103230411A Application of fucoidan polysaccharide sulfate in preparing drug for preventing and/or treating diabetic cardiomyopathy |
| 08/07/2013 | CN103230399A Methyclothiazide solid dispersoid and preparation method thereof |
| 08/07/2013 | CN103230397A Application of terfenadine in preparation of zebra fish heart function damage model |
| 08/07/2013 | CN103230392A Purposes of artemisinin compounds in preparing anti-atherosclerotic medicaments |
| 08/07/2013 | CN103230390A Application of salvianolic acid B in preparing medicines used in protection of arsenic-trioxide-induced cardiotoxicity and with synergetic antitumor effect |